China Retaliates Against European Union Device Manufacturers
Imposes a ban on European medical devicesGrowing China-EU Trade Conflict
The medical device industry is now the latest battleground in a growing China-EU trade conflict – with potential ripple effects across global supply chains and health procurement markets.
The AP reports that in an escalating trade dispute, China has barred European medical device companies from participating in government procurement contracts over 45 million yuan ($6.28 million). The ban, announced Sunday by China’s Finance Ministry, took effect immediately and is seen as retaliation for European Union trade restrictions on Chinese products.
Key Details:
- The ban applies only to non-Chinese-manufactured EU products.
- EU firms that produce within China are exempt.
- It mirrors a June EU policy excluding Chinese companies from public procurement over €5 million.
Broader EU-China Trade Tensions
- On Friday, China imposed anti-dumping duties on European brandy, particularly affecting French cognac.
- China is also investigating EU pork and dairy imports following EU actions targeting Chinese electric vehicles (EVs).
- The EU claims China’s procurement process discriminates against foreign firms, citing legal and administrative barriers.
China’s Response
China’s Ministry of Commerce said it had shown goodwill and willingness to negotiate but accused the EU of ignoring diplomatic overtures and erecting new protectionist barriers.
Read more here.
Class I Recall for Intra-Aortic Blood Pumps
Datascope/Getinge IABPs May Malfunction Due to Cable Failure The US Food and Drug Administration (FDA) announced yesterday that Datascope/Getinge is recalling certain CARDIOSAVE Hybrid and Rescue Intra-Aortic Balloon Pumps (IABP) due to a risk of device malfunction....
Urgent Action Required – Baxter LIFE2000 System
Software issue can cause potential harm or death On March 10, the US Food and Drug Administration (FDA) announced that Baxter International Inc. has issued an urgent medical device correction for its LIFE2000 Ventilation System. An issue with the device’ software may...
FDA Approval for Cancer Treatment Aid
The Food and Drug Administration (FDA) on 12 December 2022 announced the approval of Agilent's Resolution CTDX FIRST, a new in vitro diagnostic (IVD) medical device for use in the detecting a specific mutation in the KRAS gene in circulating cell-free DNA. This test...